Related Experiment Videos
Teratogenic potential of corticosteroids in humans
1Department of Biology, McGill University, Montreal, Canada.
Teratology
|January 1, 1995
Summary
Corticosteroids show minimal teratogenic potential. Analysis of numerous case series found no increased malformation risk in infants exposed to corticosteroids during pregnancy, suggesting their safety profile.
Area of Science:
- Pharmacology
- Teratology
- Reproductive Medicine
Background:
- Investigating the potential teratogenic effects of corticosteroid use during pregnancy is crucial for maternal and fetal health.
- Assessing the reliability of existing literature, considering potential reporting biases in case studies versus series.
Observation:
- Literature review focused on studies reporting corticosteroid exposure in pregnant women and subsequent offspring outcomes.
- Reporting bias was evident, with higher malformation rates in single case reports compared to larger case series.
- In a series of 468 exposed women, the overall malformation rate was 3.5%, consistent with the general population.
Findings:
- No statistically significant increase in overall malformations was detected in infants born to mothers using corticosteroids.
- A slight, possibly non-significant, increase in cleft palate cases (2 observed vs. 0.2 expected) warrants further investigation.
- The teratogenic potential of corticosteroids appears to be very low, below the threshold of detection in available data.
Implications:
- Current data suggest corticosteroids have a low teratogenic risk, supporting their judicious use in pregnancy when medically indicated.
- Further research may be needed to definitively clarify the risk of specific malformations like cleft palate.
- Clinicians should weigh the benefits of corticosteroid therapy against potential risks, considering the low overall teratogenic signal.